Carolyn Bertozzi | |
---|---|
Born | Carolyn Ruth Bertozzi October 10, 1966 Boston, Massachusetts, U.S. |
Education | |
Known for | Bioorthogonal chemistry |
Relatives | Andrea Bertozzi (sister) |
Awards |
|
Scientific career | |
Fields | Chemistry |
Institutions | |
Thesis | Synthesis and biological activity of carbon-linked glycosides (1993) |
Doctoral advisor | Mark D. Bednarski |
Doctoral students |
External videos | |
---|---|
"What the sugar coating on your cells is trying to tell you", TEDx Stanford | |
"Carolyn R. Bertozzi Wins 2022 AAAS Lifetime Mentor Award", AAAS, 10 February 2022 |
Carolyn Ruth Bertozzi (born October 10, 1966) is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" [2] for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer, inflammation, and viral infections like COVID-19. [3] At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. [4] Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) [5] and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory. [6]
She received the MacArthur "genius" award at age 33. [7] In 2010, she was the first woman to receive the prestigious Lemelson–MIT Prize faculty award. She is a member of the National Academy of Sciences (2005), the Institute of Medicine (2011), and the National Academy of Inventors (2013). In 2014, it was announced that Bertozzi would lead ACS Central Science , the American Chemical Society's first peer-reviewed open access journal, which offers all content free to the public. [8] Since 2021 she has been a member of the Accademia dei Lincei. [9] As an open lesbian in academia and science, Bertozzi has been a role model for students and colleagues. [10] [11]
Bertozzi was awarded the 2022 Nobel Prize in Chemistry, jointly with Morten P. Meldal and Karl Barry Sharpless, "for the development of click chemistry and bioorthogonal chemistry". [12]
Carolyn Bertozzi received her B.A., summa cum laude , in chemistry from Harvard University, where she worked with Professor Joe Grabowski on the design and construction of a photoacoustic calorimeter. [13] Grabowski was impressed with her work and required Bertozzi to write a thesis on this project, which was submitted and Bertozzi won the Thomas T. Hoopes Undergraduate Thesis Prize with a large prize money. [14] While an undergraduate, she played in several bands, notably Bored of Education with future Rage Against the Machine guitarist Tom Morello. [15] [16] After graduating from Harvard in 1988, she worked at Bell Labs with Chris Chidsey. [17]
Bertozzi completed her Ph.D. in chemistry at University of California, Berkeley in 1993 with Mark Bednarski, working on the chemical synthesis of oligosaccharide analogs. [18] [19] While at Berkeley, she discovered that viruses can bind to sugars in the body. [20] The discovery led to her field of research, glycobiology. During Bertozzi's third year of graduate school, Bednarski was diagnosed with colon cancer, which resulted in him taking a leave of absence and changing his career path by enrolling in medical school. This left Bertozzi and the rest of the lab to complete their Ph.D. work with no direct supervision. [21] [22]
After graduating from Berkeley with a Ph.D., Bertozzi was a postdoctoral fellow at University of California, San Francisco (UCSF) with Steven Rosen, where she studied the activity of endothelial oligosaccharides in promoting cell adhesion at inflammation sites. [23] [24] While working with Rosen at UCSF, Bertozzi was able to modify the protein and sugar molecules in the walls of living cells so that the cells accept foreign materials such as implants. [25]
In 1996 Bertozzi became a faculty member in the UC Berkeley College of Chemistry [26] and a faculty scientist at Lawrence Berkeley National Laboratory, where she served as the director of the Molecular Foundry. [23] [27] She has been an investigator with HHMI since 2000. [6] In 1999, while working with HHMI and at Berkeley, she founded the field of bioorthogonal chemistry and coined the term in 2003. [28] [29] [30] This new field and technique allows researchers to chemically modify molecules in living organisms and not interrupt the processes of the cell. [31] In 2015, Bertozzi moved to Stanford University to join the ChEM-H Institute. [32]
Bertozzi studies the glycobiology of underlying diseases such as cancer, inflammatory disorders such as arthritis, and infectious diseases such as tuberculosis. In particular, Bertozzi has advanced the understanding of cell surface oligosaccharides involved in cell recognition and inter-cellular communication. Bertozzi has applied the techniques of bioorthogonal chemistry to study glycocalyx, the sugars that surround the cell membrane. Her discoveries have advanced the field of biotherapeutics. [33] Her lab has also developed tools for research. One such development is creating chemical tools for studying glycans in living systems. [6] Her lab's development of nanotechnologies which probe biological systems lead to the development of a fast point-of-care tuberculosis test in 2018. [34] [35] In 2017, due to her lab's discovery of linking the sugars on the surface of cancer cells and their ability to avoid the immune system defenses, she was invited to speak at Stanford's TED talk, giving a talk entitled "What the sugar coating on your cells is trying to tell you". [36]
In 2001, Bertozzi and Steve Rosen co-founded Thios Pharmaceuticals in Emeryville, California, the first company to target sulfation pathways. [37] Thios Pharmaceuticals dissolved in 2005. [38]
In 2008, Bertozzi founded a startup of her own: Redwood Bioscience also in Emeryville, California. [39] Redwood Bioscience is a biotechnology company that uses SMARTag, a site-specific protein modification technology that allows small drugs to attach to sites on the proteins and can be used to help fight cancers. [20] [40] Redwood Bioscience was acquired by Catalent Pharma Solutions in 2014. Bertozzi remains a part of the advisory board for the biologics sector of the company. [40]
In 2014, she co-founded Enable Biosciences [28] of South San Francisco, California. [41] It focuses on biotechnologies for at-home diagnoses for type 1 diabetes, HIV, and other diseases. [28] [42]
Bertozzi became a co-founder of Palleon Pharma of Waltham, Massachusetts, in 2015. [43] Palleon Pharma focuses on investigating glycoimmune checkpoint inhibitors as a potential treatment for cancer. [44]
In 2017, Bertozzi helped found InterVenn Biosciences, which uses mass spectrometry and artificial intelligence to enhance glycoproteomics for target and biomarker discovery, ovarian cancer diagnostics, and predicting the successes and failures of clinical trials. [28] [45]
She co-founded Grace Science Foundation in 2018. The foundation focuses on curing NGLY1 deficiency through developing therapeutics that are efficient and inexpensive. [46]
In 2019, she co-founded both OliLux Biosciences and Lycia Therapeutics. OliLux Biosciences develops new methods for tuberculosis detection. [28] [47] The founding of Lycia Therapeutics occurred when Bertozzi's group discovered lysosome-targeting chimeras (LYTACs). The new molecule class may be able to degrade some cardiovascular disease and cancer targets. [48] Lycia Therapeutics focuses on developing technology which utilizes lysosome-targeting chimeras (LYTACs). [28]
Bertozzi also previously served on the research advisory board of several pharmaceutical companies including GlaxoSmithKline, and until 2021 Eli Lilly. [49]
Bertozzi has over 600 publications on Web of Science; the most cited are:
Bertozzi grew up in Lexington, Massachusetts, the daughter of the late Norma Gloria (Berringer) and William Bertozzi. [92] Her father was of Italian descent. [93] [94] Her maternal grandparents were from Nova Scotia, Canada. [14] She has two sisters, one of whom, Andrea Bertozzi, is on the mathematics faculty at the University of California, Los Angeles. [95] Her father was a physics professor at the Massachusetts Institute of Technology. [96] [23]
Bertozzi and her two sisters grew up around science. Because their father was a physics professor, when asked what she and her sisters wanted to be when they grew up, the answer was unanimous: a nuclear physicist. The three girls would attend MIT camps, as their father dreamt that they would attend MIT due to a "mixture of pride and the promise of free tuition." To William's dismay, Carolyn attended Harvard instead because the school offered strengths outside of just science. [23]
Bertozzi briefly considered a career in music. In high school, she won several awards for music compositions and musical accomplishments. Her talent on the keyboard earned her offers as a music major from several university rock bands, but she felt that she was "always centered on the sciences". [23] Bertozzi is a lesbian and has been out since the late 1980s. [97]
In mathematics, orthogonality is the generalization of the geometric notion of perpendicularity. Whereas perpendicular is typically followed by to when relating two lines to one another, orthogonal is commonly used without to.
Gertrude "Trudy"Belle Elion was an American biochemist and pharmacologist, who shared the 1988 Nobel Prize in Physiology or Medicine with George H. Hitchings and Sir James Black for their use of innovative methods of rational drug design for the development of new drugs. This new method focused on understanding the target of the drug rather than simply using trial-and-error. Her work led to the creation of the anti-retroviral drug AZT, which was the first drug widely used against AIDS. Her well known works also include the development of the first immunosuppressive drug, azathioprine, used to fight rejection in organ transplants, and the first successful antiviral drug, acyclovir (ACV), used in the treatment of herpes infection.
The UC Berkeley College of Chemistry is one of the fifteen schools and colleges at the University of California, Berkeley. It houses the department of chemistry and the department of chemical and biomolecular engineering.
Karl Barry Sharpless is an American stereochemist. He is a two-time Nobel laureate in Chemistry known for his work on stereoselective reactions and click chemistry.
Wendell Meredith Stanley was an American biochemist, virologist and Nobel laureate.
The Wolf Prize in Chemistry is awarded annually by the Wolf Foundation in Israel. It is one of the six Wolf Prizes established by the Foundation and awarded since 1978; the others are in Agriculture, Mathematics, Medicine, Physics and Arts.
Thomas Robert Cech is an American chemist who shared the 1989 Nobel Prize in Chemistry with Sidney Altman for their discovery of the catalytic properties of RNA. Cech discovered that RNA could itself cut strands of RNA, suggesting that life might have started as RNA. He found that RNA can not only transmit instructions, but that it can act as a speed up the necessary reactions.
Randy Wayne Schekman is an American cell biologist at the University of California, Berkeley, former editor-in-chief of Proceedings of the National Academy of Sciences and former editor of Annual Review of Cell and Developmental Biology. In 2011, he was announced as the editor of eLife, a new high-profile open-access journal published by the Howard Hughes Medical Institute, the Max Planck Society and the Wellcome Trust launching in 2012. He was elected to the National Academy of Sciences in 1992. Schekman shared the 2013 Nobel Prize for Physiology or Medicine with James Rothman and Thomas C. Südhof for their ground-breaking work on cell membrane vesicle trafficking.
Click chemistry is an approach to chemical synthesis that emphasizes efficiency, simplicity, selectivity, and modularity in chemical processes used to join molecular building blocks. It includes both the development and use of "click reactions", a set of simple, biocompatible chemical reactions that meet specific criteria like high yield, fast reaction rates, and minimal byproducts. It was first fully described by Sharpless, Hartmuth C. Kolb, and M. G. Finn of The Scripps Research Institute in 2001. In this seminal paper, Sharpless argued that synthetic chemistry could emulate the way nature constructs complex molecules, using efficient reactions to join together simple, non-toxic building blocks.
Roger Yonchien Tsien was an American biochemist. He was a professor of chemistry and biochemistry at the University of California, San Diego and was awarded the Nobel Prize in Chemistry in 2008 for his discovery and development of the green fluorescent protein, in collaboration with organic chemist Osamu Shimomura and neurobiologist Martin Chalfie. Tsien was also a pioneer of calcium imaging.
Morten Peter Meldal is a Danish chemist and Nobel laureate. He is a professor of chemistry at the University of Copenhagen in Copenhagen, Denmark. He is best known for developing the CuAAC-click reaction, concurrently with but independent of Valery V. Fokin and K. Barry Sharpless.
The term bioorthogonal chemistry refers to any chemical reaction that can occur inside of living systems without interfering with native biochemical processes. The term was coined by Carolyn R. Bertozzi in 2003. Since its introduction, the concept of the bioorthogonal reaction has enabled the study of biomolecules such as glycans, proteins, and lipids in real time in living systems without cellular toxicity. A number of chemical ligation strategies have been developed that fulfill the requirements of bioorthogonality, including the 1,3-dipolar cycloaddition between azides and cyclooctynes, between nitrones and cyclooctynes, oxime/hydrazone formation from aldehydes and ketones, the tetrazine ligation, the isocyanide-based click reaction, and most recently, the quadricyclane ligation.
Copper-free click chemistry is a bioorthogonal reaction as a variant of an azide-alkyne Huisgen cycloaddition. By eliminating cytotoxic copper catalysts, the reaction proceeds without live-cell toxicity. It was developed as a faster alternative to the Staudinger ligation with the first generation of Cu-free click chemistry, producing rate constants over 63 times faster.
Jennifer Anne Doudna is an American biochemist who has pioneered work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the department of chemistry and the department of molecular and cell biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997.
Robert Eric Betzig is an American physicist who works as a professor of physics and professor of molecular and cell biology at the University of California, Berkeley. He is also a senior fellow at the Janelia Farm Research Campus in Ashburn, Virginia.
This is a list of women chemists. It should include those who have been important to the development or practice of chemistry. Their research or application has made significant contributions in the area of basic or applied chemistry.
Jessica R. Kramer is an American biomedical engineer working as an Assistant Professor of Bio-engineering and Adjunct Assistant Professor of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. Kramer’s research lab focuses on the synthesis and application of glycopolypeptides.
Ellen Sletten is an American chemist who is the John McTague Career Development Chair at University of California, Los Angeles. Her research considers the use of physical organic chemistry for diagnostics and medical therapies.
Jennifer Ann Prescher is an American chemist who is a professor of chemistry at the University of California, Irvine. Her research considers the development of bioorthogonal, bioluminescent tools for the noninvasive, real-time imaging of immunometabolism. She was recognized with the 2023 American Chemical Society Arthur C. Cope Scholar Award.